₹ 3,494.44 Cr
2.04%
BSE Healthcare Index (TRI)
INF769K01EB0
5000.0
1000.0
99
Mr. Vrijesh Kasera, Mr. Tanmay Mehta
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Mirae Asset Healthcare Fund Regular IDCW | 13.31 | 20.38 | 13.11 |
| Benchmark | - | - | - |
Equity
Debt
Others
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns. There is no assurance that the investment objective of the scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.15 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 9.79 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 6.8 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.62 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 5.51 |
| Dr. Reddys Laboratories Ltd | 4.84 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 4.78 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 3.78 |
| ALKEM LABORATORIES LIMITED EQ | 3.76 |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 3.39 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 98.08 |
| Chemicals | 1.9 |
| Scheme Name | 5Y (%) |
|---|---|
| Mirae Asset Healthcare Reg IDCW | 13.11 |